The estimated economic impact of non-influenza related upper respiratory tract infections is $40 billion annually in the US.1
It is estimated that adults get 2 – 4 upper respiratory tract infections each year while children average 6 – 12 upper respiratory tract infections a year.
A respiratory tract infection can be the result of one of dozens of viral or bacterial pathogens. The symptoms caused by these different pathogens are nearly indistinguishable, but how a healthcare provider chooses to treat a respiratory infection may depend greatly on a rapid and accurate diagnosis of the responsible pathogen.
A New Tool in the Fight Against Respiratory Tract Infections:
MicroPathID – Respiratory Pathogen Panel (RPP) – Uses real-time PCR to identify the 22 viral and bacterial targets that cause respiratory infections.
Utilizing the MicroPathID-RPP Panel, Poplar Healthcare tests for common pathogens including viruses and bacteria that cause respiratory infections.
Rapid PCR Detection of Viral Targets
Respiratory Syncytial Virus A
Respiratory Syncytial Virus B
Parainfluenza virus 1
Parainfluenza virus 2
Parainfluenza virus 3
Parainfluenza virus 4
Rapid PCR Detection of Bacterial Targets
Rapid and accurate diagnostic testing for respiratory pathogens may aid healthcare providers in diagnosing patients, which may improve patient management, help limit the spread of disease, and reduce overall healthcare costs.
Clinical Advantages: MicroPathID – RPP Panel
- Rapid PCR results on pathogen identification
- 12 – 24 hours from specimen receipt
- Improved Sensitivity
- 3-5X more sensitive than conventional culture
- Can detect polymicrobial infections
- Unaffected by concurrent antibiotic use
Obtain a nasopharyngeal specimen via swab and collection kit provided by Poplar Healthcare.
Detect and identify multiple causative bacterial and viral agents of respiratory infections within 12 – 24 hours from specimen receipt.